Acculi Labs, a deep-tech life growth solution provider, has secured $1.5 million in a new investment round, valuing the company at $25 million. The investment was led by Sabi Holding India Ltd. Based in Bengaluru, Acculi Labs previously raised Rs 5 crore in seed funding from PirE Ventures in 2020.
The new funds will be used to accelerate the development of its conscious AI insights systems, improve manpower, enhance operational efficiency, and support infrastructure development, according to a press release from the company.
Founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs is dedicated to providing home-based care solutions for patients. Its flagship product, Lyfas, facilitates regular early diagnostics and monitoring for asymptomatic patients, allowing them to seek medical advice at an early stage.
The company has expanded its offerings from an initial cardiac health assessment system to a comprehensive suite of health solutions with the introduction of Lyfas. The platform’s mobile application can non-invasively capture psychophysiological biomarkers and deliver a detailed health report within three minutes.
Additionally, Acculi Labs has developed Lyra, an advanced conscious AI designed to bridge the gap between carbon and silicon life forms. The company also launched the Lyfas Udyam initiative, which supports small entrepreneurs by providing a micro-entrepreneurial circular economy, leveraging ecosystem processes and financial resources to help them start and manage their businesses.
